Straitstimes.com header logo

Choose edition

Search

singapore

asia

world

opinion

life

business

sport

Visual

Podcasts

STClassifieds

Paid press releases

Advertise with us

FAQs

Contact us

 

Medical technology sector

‘It’s still working’: More are living with cancer as era of targeted drugs takes hold

Menta “Steve” Wallace and his wife, Jo Linda, at their home in Texas. Menta is taking the experimental pancreatic cancer drug daraxonrasib.
Menta “Steve” Wallace and his wife, Jo Linda, at their home in Texas. Menta is taking the experimental pancreatic cancer drug daraxonrasib.

J&J drug Erleada reduces risk of prostate cancer spread, death

Prostrate cancer patients who were on Erleada and hormone-blocking therapy went more than six years before requiring subsequent treatment.
Prostrate cancer patients who were on Erleada and hormone-blocking therapy went more than six years before requiring subsequent treatment.

Lung cancer patients on drug from China’s Akeso lived longer

The new study by Chinese firm Akeso targeted squamous non-small cell lung cancer, a condition often linked with smoking.
The new study by Chinese firm Akeso targeted squamous non-small cell lung cancer, a condition often linked with smoking.

Experimental pancreatic cancer pill doubles survival chances, boosts quality of life

Revolution Medicine’s daraxonrasib drug reduced the time from diagnosis of pancreatic cancer to a patient’s death to 13.2 months versus 6.7 months for those on standard chemotherapy.
Revolution Medicine’s daraxonrasib drug reduced the time from diagnosis of pancreatic cancer to a patient’s death to 13.2 months versus 6.7 months for those on standard chemotherapy.

Doctors, this is why our patients are using ChatGPT

ChatGPT behaved the way this doctor wished modern medicine and its practitioners would.
ChatGPT behaved the way this doctor wished modern medicine and its practitioners would.

From lab idea to $2.9b start-up: Ultrasound destroys cancer without scalpels

HistoSonics, founded by China-born scientist Zhen Xu, pioneers a technique that uses ultrasound technology to target cancer cells.
HistoSonics, founded by China-born scientist Zhen Xu, pioneers a technique that uses ultrasound technology to target cancer cells.

AI spots pancreatic cancer years before it shows up: US study

More than 85 per cent of pancreatic cancer cases are found at a stage where treatment is largely limited to easing symptoms, with the five-year survival rate at about 10 per cent globally.
More than 85 per cent of pancreatic cancer cases are found at a stage where treatment is largely limited to easing symptoms, with the five-year survival rate at about 10 per cent globally.

US approves first-of-its-kind gene therapy for rare form of hearing loss

The treatment was developed by American biotechnology company Regeneron.
The treatment was developed by American biotechnology company Regeneron.

Pharmacists at TTSH turn medicine boxes green, saving $400,000 in packaging cost over four years

Tan Tock Seng Hospital pharmacists designed a single-material paper medication box (right), removing the plastic component of the old box (left), and making it recyclable in NEA’s blue recycling bins.
Tan Tock Seng Hospital pharmacists designed a single-material paper medication box (right), removing the plastic component of the old box (left), and making it recyclable in NEA’s blue recycling bins.

Fake X-rays created by AI fool radiologists – and even AI itself

Only 41 per cent of 17 radiologists from 12 hospitals in six countries spontaneously identified AI-generated images.
Only 41 per cent of 17 radiologists from 12 hospitals in six countries spontaneously identified AI-generated images.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

Download the app

Get unlimited access to exclusive stories and incisive insights from the ST newsroom
Subscribe Placeholder
MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.